Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
About
Mankind Pharma Ltd.
NSE: MANKIND
|
BSE: 543904
|
ISIN: INE634S01028
|
Industry: Pharmaceuticals
Analyst Downgrade
|
Expensive Performer
2414.2000
8.20
(
0.34
%)
NSE
Jun 19, 2026
15:31 PM
26.42% Gain from 52W Low
Volume:
484.8K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Mankind Pharma Ltd.
26 Mar 2025
Analyst Downgrade
2414.20
0.34%
MANKIND PHARMA LIMITED
Accumulate:
Mankind Pharma Ltd.
by
Geojit BNP Paribas
Target: 2691
Geojit BNP Paribas
Number of FII/FPI investors decreased from 575 to 568 in Mar 2026 qtr
More from Mankind Pharma Ltd.
Recommended
Five Interesting Stocks Today - June 19, 2026
The Baseline |
19 Jun 2026, 06:17PM
Market closes lower amid a decline in IT stocks
Trendlyne Marketwatch |
19 Jun 2026, 03:53PM
India Inc tests the tolerance of consumers for higher prices
The Baseline |
18 Jun 2026